Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative NetworkResearch in context

Summary: Background: Patients with rheumatoid arthritis (RA) are at increased risk of developing herpes zoster (HZ). This study aimed to assess the effectiveness of recombinant zoster vaccine (RZV) in reducing both the incidence of HZ and all-cause mortality among individuals with RA. Methods: We c...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ying-Li Lin, Shiow-Ing Wang, James Cheng-Chung Wei
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-07-01
Col·lecció:	EClinicalMedicine
Matèries:	Rheumatoid arthritis Herpes zoster Recombinant zoster vaccine Mortality
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2589537025002512
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!